StockData

LeMaitre Vascular vs MiMedx

LMAT and MDXG side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How LMAT and MDXG compare

LeMaitre Vascular is the larger company, worth 3.8 times as much as MiMedx ($1.7B against $464M).

LeMaitre Vascular grew revenue faster over the last twelve months (11.8% versus −22.8% for MiMedx).

LeMaitre Vascular keeps more of each dollar of sales as profit, with a net margin of 25.0% compared with −6.3% at MiMedx.

LeMaitre Vascular pays a dividend yielding 1.2%; MiMedx does not pay one.

LeMaitre Vascular scores higher on the StockData Score (22 against 12 for MiMedx), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricLMATMDXG
Size and price
Market cap$1.7B$464M
Share price$76.10$3.18
Change, 1 year−14.0%−56.9%
Change, 5 years56.1%−56.9%
Beta (5Y)−0.250.50
Employees655808
StockData Score
Total score22 (better)12
Valuation score5 (better)3
Growth score5 (better)1
Performance score5 (better)2
Health score36 (better)
Dividend score4 (better)0
Valuation
P/E26.7×–
P/S6.6×1.5× (better)
P/B4.1×2.2× (better)
EV/EBITDA15.5×–
P/FCF23.6×–
PEG0.68–
FCF yield4.2%–
Fair value$97.36$5.34
Margin of safety21.8%40.4% (better)
Growth
Revenue growth (TTM)11.8% (better)−22.8%
Revenue growth, 5Y average14.0% (better)11.0%
Net income growth (TTM)39.4% (better)−147%
EPS growth (TTM)38.3% (better)−148%
EPS growth, 5Y average19.4%–
Profitability
Gross margin72.9%77.3% (better)
Operating margin29.5% (better)−8.3%
Net margin25.0% (better)−6.3%
FCF margin28.1%–
Return on equity16.8% (better)−8.5%
Return on invested capital137% (better)−19.3%
Financial health
Debt / equity–0.00
Interest coverage14.9×–
Current ratio16.31 (better)4.35
Altman Z-score6.86 (better)6.29
Piotroski F-score66
Dividends and buybacks
Dividend yield1.2%–
Payout ratio31.2%–
Years of dividend growth14–
Dividend growth, 5Y average16.1%–
Buyback yield0.10%–
Shareholder yield1.3% (better)0.00%
Ownership
Held by institutions100.0%79.9%
Held by insiders9.0%2.9%
Insider net buying, 12 months−$30.0M$0 (better)
Short interest, % of float8.0%6.3%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.